Surmodics Announces SWING Trial 12-Month Data to be Presented at VEITHsymposium on November 16
35-subject SWING Trial evaluates the safety, efficacy of Surmodics’ Sundance™ Sirolimus Drug-Coated Balloon EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, announced today that Professor Ramon Varcoe will present 12-month data from the SWING Trial, a…